Acute Decompensated Heart Failure (ADHF). A major clinical unmet need and market.
preCARDIA’S current technology, a proprietary balloon catheter and pump controller, is designed to address ADHF via intermittent superior vena cava (SVC) occlusion. By limiting venous return to the heart, preCARDIA treats fundamental ADHF clinical hemodynamic targets.
The company was founded & incubated by MD Start and is now located in St. Paul, MN USA.